Fresenius Medical Care AG & Co. KGaA
FMS | NYSE
$22.61
+$0.14 (+0.62%)
At close: Nov 2, 2026, 4:00 PM ET
$22.61
$0.00 (0.00%)
After-hours:
Nov 2, 2026, 4:00 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 19.43B | 19.36B | 19.63B | 19.64B | 19.52B | 19.49B | 19.34B | 19.24B | 19.41B | 19.47B | 19.45B | 19.46B | 19.62B | 19.55B | 19.4B | 19.05B | 18.39B | 17.96B | 17.62B | 17.37B | 17.34B | 17.58B |
Cost of Revenue | 14.31B | 14.33B | 14.6B | 14.73B | 14.7B | 14.73B | 14.58B | 14.4B | 14.5B | 14.52B | 14.53B | 14.54B | 14.68B | 14.57B | 14.39B | 14.07B | 13.39B | 12.91B | 12.54B | 12.27B | 12.15B | 12.25B |
Gross Profit | 5.12B | 5.02B | 5.03B | 4.91B | 4.81B | 4.77B | 4.76B | 4.84B | 4.92B | 4.95B | 4.92B | 4.92B | 4.94B | 4.99B | 5.01B | 4.98B | 5.01B | 5.04B | 5.08B | 5.11B | 5.2B | 5.33B |
Operating Income | 1.89B | 1.82B | 1.83B | 1.68B | 1.64B | 1.67B | 1.53B | 1.56B | 1.42B | 1.35B | 1.37B | 1.29B | 1.44B | 1.43B | 1.51B | 1.61B | 1.64B | 1.73B | 1.85B | 1.86B | 1.99B | 2.22B |
Interest Income | 62.1M | 69.25M | 69.61M | 77.56M | 75.41M | 71.55M | 72.24M | 77.53M | 85.53M | 91.53M | 87.87M | 85.75M | 76.8M | 65.55M | 67.66M | 71.27M | 70.81M | 72.03M | 73.17M | 59.3M | 51.24M | 48.46M |
Pretax Income | 1.5B | 1.47B | 1.51B | 1.18B | 1.16B | 1.15B | 1.06B | 1.22B | 1.08B | 1.01B | 1.03B | 965.62M | 1.13B | 1.12B | 1.22B | 1.33B | 1.37B | 1.45B | 1.57B | 1.57B | 1.67B | 1.88B |
Net Income | 937.78M | 944.67M | 978.37M | 718.19M | 656.42M | 618.15M | 537.89M | 658.91M | 529.88M | 482.88M | 497.93M | 448.8M | 594.9M | 602.04M | 673.41M | 763.34M | 806.29M | 877.72M | 969.31M | 917.75M | 998.21M | 1.13B |
Selling & General & Admin | 2.98B | 3.03B | 3.03B | 3.09B | 3.14B | 3.12B | 3.14B | 3.15B | 3.19B | 3.19B | 3.2B | 3.31B | 3.33B | 3.31B | 3.32B | 3.19B | 3.1B | 3.17B | 3.1B | 3.15B | 3.13B | 3.01B |
Research & Development | 154.32M | 152.8M | 157.98M | 169.41M | 171.71M | 179.59M | 183.91M | 199.83M | 212.79M | 223.79M | 231.99M | 228.05M | 236.53M | 234.95M | 228.62M | 234.33M | 225.21M | 221.81M | 220.78M | 205.45M | 198.01M | 196.5M |
Other Expenses | 98.63M | 20.01M | 11.4M | -22.87M | -132.99M | -198.85M | -102.74M | -73.75M | 97.06M | 181.06M | 126.87M | 95.24M | -69.57M | 14.12M | -49.34M | -49.54M | 36.23M | -77.88M | -92.18M | -115.86M | -119M | -100.48M |
Operating Expenses | 3.23B | 3.2B | 3.2B | 3.23B | 3.18B | 3.1B | 3.22B | 3.27B | 3.5B | 3.59B | 3.56B | 3.63B | 3.5B | 3.56B | 3.5B | 3.37B | 3.36B | 3.32B | 3.22B | 3.24B | 3.21B | 3.1B |
Interest Expense | 382.97M | 381.99M | 384.41M | 386.44M | 392.34M | 398.76M | 406.89M | 417.31M | 432.31M | 434.31M | 425.46M | 414.07M | 392.6M | 371.93M | 360.14M | 355.14M | 346.63M | 345.48M | 353.6M | 357.19M | 368.38M | 388.34M |
Selling & Marketing Expenses | 390.93M | 575.18M | 584.13M | 721.53M | 735.73M | 742.46M | 776.53M | 581.86M | 583.79M | 392.82M | 405.53M | 405.53M | 203.28M | 203.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 17.54B | 17.54B | 17.8B | 17.97B | 17.88B | 17.82B | 17.8B | 17.68B | 17.99B | 18.12B | 18.08B | 18.17B | 18.18B | 18.13B | 17.89B | 17.44B | 16.75B | 16.23B | 15.77B | 15.51B | 15.35B | 15.36B |
Income Tax Expense | 314.25M | 302.68M | 320.97M | 275.53M | 316.84M | 337.58M | 316.04M | 341.5M | 312.97M | 294.97M | 300.46M | 297.04M | 321.26M | 303.19M | 324.95M | 320.62M | 313.38M | 325.75M | 352.83M | 412.74M | 432.09M | 493.86M |
Shares Outstanding (Basic) | 539.2M | 550.44M | 571.81M | 584.67M | 586.83M | 586.83M | 1.17B | 1.17B | 1.17B | 1.17B | 879.91M | 879.91M | 879.91M | 879.91M | 1.17B | 1.17B | 1.17B | 1.17B | 887.33M | 887.33M | 887.33M | 887.33M |
Shares Outstanding (Diluted) | 539.2M | 550.44M | 571.81M | 584.67M | 586.83M | 586.83M | 1.17B | 1.17B | 1.17B | 1.17B | 879.91M | 879.91M | 879.91M | 879.91M | 1.17B | 1.17B | 1.17B | 1.17B | 887.33M | 887.33M | 887.33M | 887.33M |
EPS (Basic) | 1.66 | 1.64 | 1.69 | 1.18 | 0.89 | 0.67 | 0.47 | 0.62 | 0.53 | 0.53 | 0.57 | 0.48 | 0.57 | 0.54 | 0.57 | 0.72 | 0.83 | 0.95 | 1.10 | 1.03 | 1.13 | 1.27 |
EPS (Diluted) | 1.66 | 1.64 | 1.69 | 1.18 | 0.89 | 0.67 | 0.47 | 0.62 | 0.53 | 0.53 | 0.57 | 0.48 | 0.57 | 0.54 | 0.57 | 0.72 | 0.83 | 0.95 | 1.10 | 1.03 | 1.13 | 1.27 |
EBITDA | 3.42B | 3.42B | 3.4B | 3.17B | 3.17B | 3.17B | 3.21B | 3.33B | 3.29B | 3.27B | 3.21B | 3.2B | 3.39B | 3.35B | 3.42B | 3.46B | 3.39B | 3.45B | 3.55B | 3.69B | 3.8B | 4.05B |
EBIT | 1.87B | 1.85B | 1.9B | 1.57B | 1.55B | 1.55B | 1.46B | 1.64B | 1.51B | 1.45B | 1.46B | 1.38B | 1.52B | 1.49B | 1.58B | 1.68B | 1.71B | 1.8B | 1.93B | 1.92B | 2.04B | 2.27B |
Depreciation & Amortization | 1.55B | 1.57B | 1.5B | 1.6B | 1.61B | 1.62B | 1.74B | 1.69B | 1.78B | 1.83B | 1.75B | 1.82B | 1.87B | 1.86B | 1.84B | 1.78B | 1.68B | 1.65B | 1.62B | 1.77B | 1.76B | 1.77B |
Add to Watchlist
Select watchlists to add or remove FMS